APstem Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
5
APstem Therapeutics General Information
Description
Developer of a novel stem cell therapy designed to eradicate difficult-to-heal diseases and overcome the challenges of aging. The company's therapy uses a novel stem cell technology that targets remedies for injuries and degenerative diseases, including diabetic ulcers, diabetes, neural damage, liver diseases, and aging-associated diseases, enabling patients to get therapies that can expand rapidly and differentiate into cell lineages originating from germ layers.
Contact Information
Website
www.apstemtx.comCorporate Office
- 48371 Fremont Boulevard
- Suite 103
- Fremont, CA 94538
- United States
Corporate Office
- 48371 Fremont Boulevard
- Suite 103
- Fremont, CA 94538
- United States
APstem Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 07-Sep-2023 | $3M | Completed | Pre-Clinical Trials | ||
| 4. Seed Round | 01-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 01-May-2019 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 17-Jan-2018 | $1M | $1M | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Stealth |
APstem Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed | 1,297,000 | $0.000010 | $0.79 | $0.79 | 1x | $0.79 | 11.55% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
APstem Therapeutics Patents
APstem Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4788793-A1 | Generation of stem cells with high plasticity | Pending | 06-Oct-2023 | ||
| WO-2025076394-A1 | Generation of stem cells with high plasticity | Inactive | 06-Oct-2023 | ||
| AU-2019345279-A1 | Human pluripotent adult stem cells | Active | 21-Sep-2018 | ||
| AU-2019345279-B2 | Human pluripotent adult stem cells | Active | 21-Sep-2018 | ||
| AU-2023200406-A1 | Human pluripotent adult stem cells | Inactive | 21-Sep-2018 | C12N5/0607 |
APstem Therapeutics Signals
APstem Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beyond Ventures | Venture Capital | Minority | ||
| Oriza Ventures | Venture Capital | Minority | ||
| InnoSpring | Venture Capital | Minority | ||
| MFund | Venture Capital | Minority | ||
| StartX (US) | Accelerator/Incubator | Minority |
APstem Therapeutics FAQs
-
When was APstem Therapeutics founded?
APstem Therapeutics was founded in 2017.
-
Where is APstem Therapeutics headquartered?
APstem Therapeutics is headquartered in Fremont, CA.
-
What is the size of APstem Therapeutics?
APstem Therapeutics has 5 total employees.
-
What industry is APstem Therapeutics in?
APstem Therapeutics’s primary industry is Drug Discovery.
-
Is APstem Therapeutics a private or public company?
APstem Therapeutics is a Private company.
-
What is APstem Therapeutics’s current revenue?
The current revenue for APstem Therapeutics is .
-
How much funding has APstem Therapeutics raised over time?
APstem Therapeutics has raised $7.3M.
-
Who are APstem Therapeutics’s investors?
Beyond Ventures, Oriza Ventures, InnoSpring, MFund, and StartX (US) have invested in APstem Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process